MedTrace Logo

A Drug Interaction Study of Montelukast and Levocetirizine

NCT01491503 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2013-04-05

No results posted yet for this study

Summary

The purpose of this study is to evaluate the drug-drug interaction between montelukast sodium and levocetirizine dihydrochloride in healthy male volunteers.

Conditions

  • Healthy

Interventions

DRUG

Levocetirizine

Levocetirizine dihydrochloride 5mg. PO. Single dose.

DRUG

montelukast sodium

Montelukast sodium 10mg. PO. Single dose.

DRUG

Montelukast & levocetirizine

Montelukast sodium 10mg \& levocetirizine dihydrochloride 5mg PO. Single dose.

Sponsors & Collaborators

  • Hanmi Pharmaceutical Company Limited

    lead INDUSTRY

Principal Investigators

  • Wooseong Huh, MD · Samsung Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
20 Years
Max Age
55 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-11-30
Primary Completion
2012-01-31
Completion
2012-01-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01491503 on ClinicalTrials.gov